There are 12 resources available
Welcome and introduction
Presenter: T. Saito, JP, S. Stacchiotti, IT, I. B. H. Tan, SG
Session: Welcome and introduction
Resources:
Slides
Webcast
Advances in NTRK-fused tumors classification and diagnosis
Presenter: C. Antonescu, US
Session: Session 1 - Advances in NTRK-fused tumors classification and diagnosis
Resources:
Slides
Webcast
Epidemiology and distribution of NTRK gene fusion in human tumors
Presenter: I. B. H. Tan, SG
Session: Session 2 - Epidemiology and distribution of NTRK gene fusion in human tumors
Resources:
Slides
Webcast
Structure and function of TRK and NTRK in ontogenesis and which are the molecular alterations of interest to consider a treatment with NTRK inhibitors
Presenter: T. Saito, JP
Session: Session 3 - Structure and function of TRK and NTRK in ontogenesis and which are the molecular alterations of interest to consider a treatment with NTRK inhibitors
Resources:
Slides
Webcast
Clinical data on larotrectinib: activity, efficacy and safety
Presenter: M. Tahara, JP
Session: Session 4
Resources:
Slides
Webcast
Clinical data on entrectinib: activity, efficacy and safety
Presenter: W. T. A. van der Graaf, NL
Session: Session 4
Resources:
Slides
Webcast
Pediatric NTRK rearranged tumor
Presenter: Y. Koga, JP
Session: Session 5 - Clinical cases: how to treat NTRK-fused tumors
Resources:
Slides
Webcast
Adult NTRK rearranged sarcoma, preoperative
Presenter: S. Stacchiotti, IT
Session: Session 5 - Clinical cases: how to treat NTRK-fused tumors
Resources:
Slides
Webcast
Adult head and neck
Presenter: L. Locati, IT
Session: Session 5 - Clinical cases: how to treat NTRK-fused tumors
Resources:
Slides
Webcast
NTRK-fused tumors: when to treat and when not to treat with NTRK inhibitors
Presenter: T. W-W. Chen, TW
Session: Session 6 - NTRK-fused tumors: when to treat and when not to treat with NTRK inhibitors
Resources:
Slides
Webcast